Announced FDA's groundbreaking initiative to replace animal testing with AI-based computational models and human-relevant methods for drug development.
How media typically covers Martin A. Makary
Referenced in coverage
The FDA is replacing animal testing with AI-based computational models, organoid testing, and real-world human data for drug safety evaluation to accelerate treatments, reduce costs, and eliminate animal experimentation.
“Announced FDA's groundbreaking initiative to replace animal testing with AI-based computational models and human-relevant methods for drug development.”